ETON PHARMACEUTICALS

eton-pharmaceuticals-logo

Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development. It was founded in 2017 and headquartered in Studio City, California.

#SimilarOrganizations #People #Event #Website #More

ETON PHARMACEUTICALS

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
2017-01-01

Address:
Studio City, California, United States

Country:
United States

Website Url:
http://www.etonpharma.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
27.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.


Current Advisors List

charles-casamento_image

Charles Casamento Board Member @ Eton Pharmaceuticals
Board_member
2017-06-01

paul-maier_image

Paul Maier Board Chairman @ Eton Pharmaceuticals
Board_member
2017-01-01

mark-baum_image

Mark Baum Board Member @ Eton Pharmaceuticals
Board_member
2017-05-01

norbert-riedel_image

Norbert Riedel Board Chairman @ Eton Pharmaceuticals
Board_member

sean-brynjelsen_image

Sean Brynjelsen Board Member @ Eton Pharmaceuticals
Board_member

Current Employees Featured

mark-baum_image

Mark Baum
Mark Baum Founder @ Eton Pharmaceuticals
Founder
2017-05-01

sean-brynjelsen_image

Sean Brynjelsen
Sean Brynjelsen Chief Executive Officer @ Eton Pharmaceuticals
Chief Executive Officer
2017-06-01

james-gruber_image

James Gruber
James Gruber CFO @ Eton Pharmaceuticals
CFO
2022-04-01

Founder


mark-baum_image

Mark Baum

Stock Details


Company's stock symbol is NASDAQ:ETON

Key Employee Changes

Date New article
2022-04-11 Eton Pharmaceuticals Names James Gruber Finance Chief

Official Site Inspections

http://www.etonpharma.com Semrush global rank: 1.42 M Semrush visits lastest month: 19.7 K

  • Host name: 149.199.83.34.bc.googleusercontent.com
  • IP address: 34.83.199.149
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Eton Pharmaceuticals"

Company | Eton Pharmaceuticals

At Eton, we donโ€™t focus on a single therapeutic area or category. Instead, we provide hope by sourcing potential therapies worldwide.See details»

Eton Pharmaceuticals

A rare opportunity to change lives. Together, we can put our care, expertise, and resources to work, providing long-needed treatments to underserved populations.See details»

Eton Pharmaceuticals Announces Appointment of Jenn Adams to โ€ฆ

DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โ€ฆSee details»

Eton Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org

Eton Pharmaceuticals is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S Food โ€ฆSee details»

Eton Pharmaceuticals, Inc. (ETON) - Yahoo Finance Canada

See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Eton Pharmaceuticals, Inc. (ETON) Company Profile & Facts

See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Eton Pharmaceuticals - Crunchbase Company Profile

Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need.See details»

Eton Pharmaceuticals | LinkedIn

Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.See details»

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 ...

DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing โ€ฆSee details»

Eton Pharmaceuticals - Craft

Oct 29, 2024 Eton Pharmaceuticals has 1 employees at their 1 location and $31.64 m in annual revenue in FY 2023. See insights on Eton Pharmaceuticals including office locations, โ€ฆSee details»

Eton Pharmaceuticals to Report First Quarter 2024 Financial โ€ฆ

DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (โ€œEtonโ€ or the "Companyโ€) (Nasdaq: ETON), an innovative pharmaceutical company focused on โ€ฆSee details»

Mission | Eton Pharmaceuticals

21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»

Eton Pharmaceuticals Announces Acquisition of FDA-Approved

Sep 13, 2022 Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral SolutionSee details»

Eton Pharmaceuticals Advances Its Commitment to Rare

15 hours ago Adds an additional commercial and strategic rare disease product to Etonโ€™s portfolio; Galzin is FDA-approved for the treatment of the ultra-rare metabolic condition of โ€ฆSee details»

News Release Details - ir.etonpharma.com

Mar 7, 2023 In addition, the Company receives royalties on three FDA-approved products and is entitled to receive milestone payments on other products. For more information, please visit โ€ฆSee details»

Business Model | Eton Pharmaceuticals

We strive to develop our therapies, file for FDA approval, and launch them with unprecedented speed. Below are a few examples of the types of value Eton tries to unlock:See details»

Eton Pharmaceuticals Advances Its Commitment to Rare Disease โ€ฆ

1 day ago Adds an additional commercial and strategic rare disease product to Etonโ€™s portfolio; Galzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson DiseaseSee details»

Partnerships | Eton Pharmaceuticals

Successfully identifying high-potential therapies . Efficiently executing clinical studies. Gaining timely regulatory approval. Establishing a robust chain to support seamless product access โ€ฆSee details»

Eton Pharmaceuticals Acquires Galzin® to Enhance Rare Disease

15 hours ago Eton Pharmaceuticals acquires FDA-approved Galzin for Wilson Disease, enhancing its rare disease treatment portfolio and patient support services.See details»

Eton Pharmaceuticals to Report Second Quarter 2022 Financial โ€ฆ

DEER PARK, Ill., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โ€ฆSee details»

linkstock.net © 2022. All rights reserved